NASDAQ:ALHC

Track all markets on TradingView - Prices are not updated in real time
Alignment Healthcare Stock Plunges 16.4% After William Blair Downgrade

Alignment Healthcare shares fell 16.4% to $7.29 after William Blair downgraded the stock to Market Perform from Outperform, with the move tied to concerns over the company’s 2027 Medicare Advantage Star Ratings.

The key issue is Alignment’s California H3815 HMO contract, which received a 3.5-star rating for 2027, down from 4.0 stars for 2026 (Benzinga). The contract is particularly important because it represents more than 75% of the company’s total health plan membership.

Medicare Advantage contracts generally need a rating of at least 4 stars to qualify for quality bonus payments, meaning the downgrade could pressure future economics for Alignment’s largest plan (Benzinga).

The company performed better across much of the rest of its portfolio, with six of seven eligible contracts receiving ratings of 4 stars or higher. However, investors appear to be focusing on the financial impact of the California downgrade rather than the broader portfolio strength.

Alignment has challenged the methodology behind the rating and said it intends to pursue administrative remedies and litigation over measures it believes should be reviewed (Benzinga).

The sharp stock decline suggests the market is pricing in a potentially meaningful hit to future bonus revenue and profitability if the H3815 rating remains below the 4-star threshold.
💬
Author
Global Finance News 10-09-26
Alignment Healthcare Shareholders Approve Key Proposals at 2025 Annual Meeting

Alignment Healthcare, Inc. held its 2025 Annual Meeting of Stockholders on June 5, 2025, with 180.7 million shares represented. Shareholders approved all management-backed proposals, including board elections, auditor ratification, and executive compensation.

Voting Results:

Board Elections:
Three Class I directors were re-elected to serve until 2028. Margaret McCarthy and Robbert Vorhoff received strong support with over 149 million votes each. Mark McClellan was re-elected with a narrower margin of 81.4 million votes in favor.

Auditor Ratification:
Stockholders overwhelmingly ratified Deloitte & Touche LLP as the Company’s independent registered public accounting firm for the 2025 fiscal year, with over 180.4 million votes in favor.

Say-on-Pay:
An advisory vote on executive compensation received broad approval, with nearly 163 million votes supporting the compensation packages of named executive officers.
💬
M
ME NEWS 06-12-25
Alignment Healthcare Chief Experience Officer Hakan Kardes Resigns, Will Support Transition Until Mid-May

Alignment Healthcare, Inc. (NASDAQ: ALHC) has announced the resignation of its Chief Experience Officer, Hakan Kardes. While his official departure from the executive role was effective immediately, he will remain employed with the company through May 16, 2025, to assist in transitioning his responsibilities to other senior team members.

The company confirmed the resignation in a regulatory filing, noting that Kardes stepped down to pursue new professional opportunities. No additional details were provided regarding his future plans or a successor for his position.

Kardes played a key role in shaping the member experience strategy at Alignment Healthcare, a company focused on providing Medicare Advantage plans with an emphasis on technology-enabled personalized care.
💬
M
ME NEWS 04-16-25
Alignment Healthcare Resolves Shareholder Litigation with $950,000 Fee Settlement
ORANGE, Calif. — Alignment Healthcare, Inc. (NASDAQ: ALHC) announced that the Delaware Court of Chancery has officially closed the shareholder litigation case Maglione v. Konowiecki, et al. following the company’s agreement to pay $950,000 in attorneys’ fees and expenses to the plaintiff’s counsel. The court’s closure order, dated April 9, 2025, concludes the matter, which originated from claims surrounding the company’s stockholders agreement.

The lawsuit, filed in 2023, became moot after Alignment entered into an amended and restated stockholders agreement with funds managed by General Atlantic and Warburg Pincus LLC on April 30, 2024. The updated agreement resolved the plaintiff’s concerns, prompting the court to dismiss the case in May 2024 while retaining jurisdiction to address the plaintiff’s counsel’s request for legal fees.

The $950,000 fee settlement was reached without any admission of wrongdoing or liability by Alignment Healthcare. The Court of Chancery did not assess the reasonableness or merits of the fee payment in its final order, which closes the case contingent upon the company confirming this notice of resolution.

The company has now fulfilled all related obligations and filed the required affidavit with the court to finalize the matter.
💬
M
ME NEWS 04-14-25